Lab-on-a-chip microfluidic systems developer, MiniFAB, is all set to display its range of disposable polymer-based microfluidic solutions at the 2012 American Association for Clinical Chemistry (AACC) Exhibit. MiniFAB adopts a “design for manufacture” approach that enables it to quickly turn around a concept into manufactured microfluidic medical and diagnostic products.
The AACC Exhibit is the largest such exposition for clinical chemistry. This is MiniFAB’s fifth year at the AACC exposition. The company will be occupying booth #2363 and the range of microfluidic solutions displayed will demonstrate integration of lab-on-chip solutions with microfluidic systems, integration of non-polymer materials like silicon dies with polymer hybrid cartridges, substrate materials with differing complexity and dimensions, integration of functional components such as electrodes, sensors, membranes, valves and filters and method of manufacturing designs with complex and challenging features.
Erol Harvey, MiniFAB’s CEO, expressed excitement over the company showcasing its products at the exhibition. Set up in 2002, MiniFAB is headquartered in Melbourne, Australia and has offices in Europe and United States. The company has received ISO 13485 certification and has executed over 500 projects globally in collaboration with partners. The company’s specialties are sample preparation by employing microfluidic lab-on-chip products and in-vitro diagnostics (IVD).